TRUPCR® ALL PCR Panel Kit
The TRUPCR® ALL PCR panel is intended for the qualitative detection of diagnostic and prognostic markers of acute lymphoblastic leukaemia (ALL) in peripheral blood samples using Real-time PCR system.
The TRUPCR® ALL PCR panel is intended for the qualitative detection of diagnostic and prognostic markers of acute lymphoblastic leukaemia (ALL) in peripheral blood samples using Real-time PCR system.
The TRUPCR® AML Panel Kit is intended for the qualitative detection of diagnostic and prognostic markers of acute myelogenous leukaemia (AML) in peripheral blood samples on conventional and Real-time PCR.
The TRUPCR® MPN Panel Kit is intended for the qualitative detection of JAK2-V617F, CALR, MPL W515K/L mutations and BCR-ABL1 translocation in Myeloproliferative neoplasms (MPNs) in peripheral blood samples using Real-time PCR.
The TRUPCR Paediatric Leukaemia Panel Kit is intended for the qualitative detection of 18 markers of paediatric leukaemia in peripheral blood samples using Real-time PCR.
TRUPCR® Leukemia Fusion Gene Panel Kit is intended for the qualitative detection of fusion diagnostic markers of acute myeloid leukemia (AML) and acute lymphoblastic leukemia in peripheral blood samples using Real-time PCR.
The TRUPCR® Acute Leukemia Panel Kit is intended for the qualitative detection of diagnostic and prognostic markers of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL) in peripheral blood samples using Real-Time PCR.
The TRUPCR® C-KIT Mutation Detection is a PCR-based in vitro diagnostic test designed to detect D816V in the C-KIT gene in genomic DNA extracted from peripheral blood of patients diagnosed with acute myelogenous leukaemia (AML) or other malignancy.
The TRUPCR® CALR Kit is qualitative assay for the detection of CALR mutations in genomic DNA from whole blood of subjects suspected of myeloproliferative neoplasms (MPN).
The TRUPCR® FLT3 Mutation Detection is a PCR-based in vitro diagnostic test designed to detect internal tandem duplications (ITD) and tyrosine kinase domain (TKD) mutation (D835-I836) in the FLT3 gene in genomic DNA extracted from mononuclear cells obtained from peripheral blood of patients diagnosed with acute myelogenous leukaemia (AML).
The Nucleophosmin (NPM1) gene is one of the most commonly mutated genes in acute myeloid leukaemia (AML), occurring in about 35% of AML patients at diagnosis and in approximately 60% of adult cytogenetically normal AML (CN-AML).
TRUPCR® NPM1 Mutation Quantitative Kit is an in vitro nucleic acid amplification assay for the qualitative detection and quantification of NPM1 mutant allelic burden in clinical samples.
TRUPCR® JAK2 Kit (V2.0) is a Real-time PCR assay for qualitative detection of V617F mutation in JAK2 (Janus Kinase 2) gene against a background of wild-type genomic DNA.
TRUPCR JAK-2 allele burden kit is a Real-time PCR assay for quantification V617F mutation in JAK-2 (Janus Kinase 2) gene against a background of wild-type genomic DNA.
Detection of the PML-RARA t(15;17) translocation is diagnostic for acute promyelocytic leukaemia (APL), although the diagnosis can also be based on morphology.
TRUPCR® PML-RARA is an in vitro nucleic acid amplification assay for the qualitative and quantitative detection of PML/RAR-alpha fusion transcripts in human clinical samples.
The TRUPCR® DPYD Mutations Detection Kit is an in vitro diagnostic test intended for the detection of clinically relevant single nucleotide polymorphisms (SNPs)
The TRUPCR® MYD88 Mutation Detection Kit is an in vitro diagnostic test intended for the qualitative detection of L265P mutation in c.794T>C in myeloid differentiation factor 88 (MYD88) gene from tumor tissue DNA (fresh, frozen or formalin fixed paraffin-embedded tissue)/bone marrow or peripheral blood.
The TRUPCR®CXCR4 Mutations Detection Kit is an in vitro diagnostic test intended for the qualitative detection of S338X mutation (c.1013C>G and c.1013C>A, NM_003467.3) in C-X-C motif chemokine receptor 4 (CXCR4) gene from human genomic DNA, extracted from whole blood/bone marrow/FFPE tissue.
The TRUPCR® IDH1/2 Mutation Detection Kit is an in vitro diagnostic test intended for the qualitative detection of IDH1/2 somatic mutations in DNA extracted from human blood (EDTA) or bone marrow (EDTA) using Real-time PCR.
The TRUPCR®MGMT Methylation Detection kit is a Methylation-specific q-PCR assay to detect MGMT Promoter methylation by using allele-specific primers to identify their target. The MGMT kit works by amplifying the epigenetically silenced MGMT promoter regions after bisulfite treatment of DNA to determine the methylation status of the MGMT promoter. β-actin serves as an endogenous internal control (IC) to check sample quality and whole process.
TRUPCR® IDH1/2 Detection & Differentiation Kit is an in vitro diagnostic test intended for the qualitative detection and differentiation of IDH1/2 somatic mutations in genomic DNA extracted from human blood (EDTA) or bone marrow (EDTA) and FFPE Tissue using Real-time PCR.The results from the TRUPCR® IDH1/2 Detection & Differentiation Kit must be interpreted within the context of all relevant clinical and laboratory findings.Each reaction contains an endogenous internal control in order to control for PCR inhibition.
The TRUPCR® dPCR BCR::ABL1 kit (RUO)– Major is intended for the quantitative detection of the BCR::ABL1 Major fusion gene transcript in bone marrow or peripheral blood samples of chronic myeloid leukemia (CML) using the QuantStudio Absolute Q Digital PCR (dPCR) System.
The TRUPCR® TPMT Mutation Detection Kit is an in vitro diagnostic test intended for the qualitative detection of four clinically relevant single nucleotide polymorphisms (SNPs); c.238G>C, c.460G>A, c.626-1G>A and c.719A>G (NM_000367.2) in Thiopurine S-methyltransferase (TPMT) gene from human genomic DNA, extracted from whole blood/bone marrow/FFPE.
Chronic myeloid leukaemia (CML) is characterized by the consistent involvement of the Philadelphia chromosome (Ph) and the BCR-ABL fusion gene, which derives from the reciprocal translocation t(9;22)(q34;q11) between chromosome 9 and 22.
TRUPCR® BCR-ABL QT kit is a RT-qPCR test for the quantitative detection of BCR-ABL fusion transcripts in bone marrow or peripheral blood samples.
The BCR-ABL1 Detection Kit is intended for the qualitative detection of BCR-ABL1 fusion gene (Major-BCR, minor-BCR, and micro -BCR) in bone marrow or peripheral blood samples using Real-time PCR.
TRUPCR® BCR-ABL1 Transcript Screening Kit is a RT-qPCR test for the detection and differentiation of BCR-ABL fusion transcripts in bone marrow or peripheral blood samples.
The TRUPCR® EGFR PCR Kit is an in vitro diagnostic test intended for the qualitative detection of EGFR somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue.
The TRUPCR® KRAS PCR Kit (K-RAS Kit) is an in vitro diagnostic test intended for the qualitative detection of KRAS somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue.
The TRUPCR® MGMT Methylation Detection Kit is intended to detect methylation of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter which predicts its response to alkylating agent (TMZ) in patients with glioblastoma.
The TRUPCR® BRAF Mutation Kit is an in vitro diagnostic test intended for the qualitative detection of BRAF somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue.
The TRUPCR® NRAS Mutation Kit is an in vitro diagnostic test intended for the qualitative detection of NRAS somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue.
The TRUPCR® ROS1 Gene Fusions Detection Kit is intended for the qualitative detection of 14 ROS1 gene fusions in human NSCLC formalin-fixed paraffin- embedded (FFPE) tissue samples using real time PCR system.
The TRUPCR® ALK Fusion Detection Kit is intended for the qualitative detection of 29 EML4-ALK fusions in human NSCLC formalin-fixed paraffin-embedded (FFPE) tissue samples using Real-time PCR. The human ABL1 gene serves as an internal positive control for human nucleic acid, also included in this kit.
The TRUPCR® Colorectal Cancer Mutation Panel Kit is an in vitro diagnostic test intended for the qualitative detection of KRAS, NRAS & BRAF somatic mutations in genomic DNA extracted from fresh, frozen or formalin fixed paraffin-embedded (FFPE) tissue using Real-time PCR.
With an experienced team and innovative products, TRUPCR Europe develops, manufactures and supplies high quality qPCR and NGS molecular diagnostic products throughout the World.
We are experts in Oncology, Infectious Disease and Genetics.
Unit 6, Williams House
Lloyd Street North
Manchester Science Park
Manchester M15 6SE
UK
General enquires: info@trupcr.com
Technical: techsupport@trupcr.com
Sales: sales@trupcr.com
Orders: orders@trupcr.com
Tel: +44 (0) 161 943 4731

We value your privacy
We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
These cookies are needed for adding comments on this website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
WPForms is a user-friendly WordPress plugin for creating custom forms with drag-and-drop functionality.
Marketing cookies are used to follow visitors to websites. The intention is to show ads that are relevant and engaging to the individual user.
Google Maps is a web mapping service providing satellite imagery, real-time navigation, and location-based information.
Service URL: policies.google.com (opens in a new window)